A P Passmore - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A P Passmore

Showing results (31-40 of 56) with videos related to

Pageof 6

Sort By:

QJM : Monthly Journal of the Association of Physicians|November 13, 2001

Plasma somatostatin and gastrointestinal peptides in Alzheimer's disease and vascular dementiaC J Foy, J Ardill, D Filmore, et al.

Pharmacotherapy|July 23, 1999

Pharmaceutical care of patients with congestive heart failure: interventions and outcomesS Varma, J C McElnay, C M Hughes, et al.

European Journal of Clinical Pharmacology|January 1, 1987

The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenalineG B Kondowe, S Copeland, A P Passmore, et al.

Pharmacology|October 1, 1993

A comparison of Agiolax and lactulose in elderly patients with chronic constipationA P Passmore, K W Davies, P G Flanagan, et al.

The Quarterly Journal of Medicine|November 1, 1991

The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertensionA P Passmore, E M Whitehead, V Crawford, et al.

Aging & Mental Health|October 19, 2020

Anticholinergic drug use and risk of mortality for people with dementia in Northern IrelandA J McMichael, E Zafeiridi, M Ryan, et al.

QJM : Monthly Journal of the Association of Physicians|August 31, 2001

Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehydeL T McGrath, B M McGleenon, S Brennan, et al.

QJM : Monthly Journal of the Association of Physicians|April 21, 1999

Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's diseaseC J Foy, A P Passmore, M D Vahidassr, et al.

BMJ (Clinical Research Ed.)|June 29, 1996

Neuroleptic prescribing in residents of nursing homes. Geographical differences make extrapolation difficultA P Passmore, V L Crawford, T R Beringer, et al.

International Journal of Geriatric Psychiatry|February 6, 2004

DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementiaE Kalbe, J Kessler, P Calabrese, et al.

Pageof 6

Search research articles

Showing results (31-40 of 56) with videos related to

Sort By:

Pageof 6

QJM : Monthly Journal of the Association of Physicians|November 13, 2001

Plasma somatostatin and gastrointestinal peptides in Alzheimer's disease and vascular dementiaC J Foy, J Ardill, D Filmore, et al.

Pharmacotherapy|July 23, 1999

Pharmaceutical care of patients with congestive heart failure: interventions and outcomesS Varma, J C McElnay, C M Hughes, et al.

European Journal of Clinical Pharmacology|January 1, 1987

The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenalineG B Kondowe, S Copeland, A P Passmore, et al.

Pharmacology|October 1, 1993

A comparison of Agiolax and lactulose in elderly patients with chronic constipationA P Passmore, K W Davies, P G Flanagan, et al.

The Quarterly Journal of Medicine|November 1, 1991

The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertensionA P Passmore, E M Whitehead, V Crawford, et al.

Aging & Mental Health|October 19, 2020

Anticholinergic drug use and risk of mortality for people with dementia in Northern IrelandA J McMichael, E Zafeiridi, M Ryan, et al.

QJM : Monthly Journal of the Association of Physicians|August 31, 2001

Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehydeL T McGrath, B M McGleenon, S Brennan, et al.

QJM : Monthly Journal of the Association of Physicians|April 21, 1999

Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's diseaseC J Foy, A P Passmore, M D Vahidassr, et al.

BMJ (Clinical Research Ed.)|June 29, 1996

Neuroleptic prescribing in residents of nursing homes. Geographical differences make extrapolation difficultA P Passmore, V L Crawford, T R Beringer, et al.

International Journal of Geriatric Psychiatry|February 6, 2004

DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementiaE Kalbe, J Kessler, P Calabrese, et al.

Pageof 6